Enovis Corp
NYSE:ENOV
Relative Value
The Relative Value of one
ENOV
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 21.86 USD,
Enovis Corp
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
ENOV Competitors Multiples
Enovis Corp Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Enovis Corp
NYSE:ENOV
|
1.3B USD | 0.6 | -0.9 | 8.6 | 446.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
195.4B USD | 4.4 | 29.9 | 17 | 23.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
172.4B USD | 17.1 | 60.4 | 45.8 | 56.3 | |
| US |
|
Stryker Corp
NYSE:SYK
|
140B USD | 5.6 | 43.1 | 21.9 | 26.5 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
127.3B USD | 3.7 | 26.7 | 15 | 21.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
110.9B USD | 5.5 | 38.3 | 22.8 | 30.5 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.8B EUR | 2 | 21.6 | 12 | 16.9 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
50.2B USD | 11.7 | 47.3 | 33.8 | 37.3 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
50.5B USD | 2.3 | 30 | 11.4 | 19.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
44.4B USD | 7.5 | 32.5 | 23 | 25.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
36.6B USD | 6.8 | 24.6 | 17.4 | 19.3 |